Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma

Por Griffin, Liezel L., Cove-Smith, Laura, Alachkar, Hana, Radford, John A., Brooke, Rebecca, Linton, Kim M.
Publicado no JAAD Case Rep (2018)

Automated prognostic pattern detection shows favourable diffuse pattern of FOXP3(+) Tregs in follicular lymphoma

Por Nelson, Lilli S, Mansfield, James R, Lloyd, Roslyn, Oguejiofor, Kenneth, Salih, Zena, Menasce, Lia P, Linton, Kim M, Rose, Chris J, Byers, Richard J
Publicado no Br J Cancer (2015)

RIVA – a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial

Por Lim, Sean H., Linton, Kim M., Collins, Graham P., Dhondt, Joke, Caddy, Joshua, Rossiter, Liz, Vadher, Karan, Fines, Keira, Rogers, Laura E., Fernando, Diana, Stanton, Louise, Davies, Andrew J., Johnson, Peter W. M., Griffiths, Gareth
Publicado no Trials (2018)